PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Intelligence. Author manuscript; available in PMC 2010 November 1.
Published in final edited form as:
Intelligence. 2009 November 1; 37(6): 529–534.
doi:  10.1016/j.intell.2008.12.001
PMCID: PMC2802348
NIHMSID: NIHMS158092

Cognition and incident coronary heart disease in late midlife: The Whitehall II study

Abstract

The purpose of this study was to investigate whether cognitive function in midlife predicts incident coronary heart disease (CHD), followed up over 6 years. Data on 5292 (28% women, mean age 55) individuals free from CHD at baseline were drawn from the British Whitehall II study. We used Cox regression to model the association between cognition and CHD in analyses adjusted for socio-demographic variables, cardiovascular risk factors and health behaviors. The results show a one standard deviation lower score on the “general” cognitive measure and measures of reasoning and vocabulary to be associated with elevated CHD risk. There was some evidence that these effects differed between high and low socioeconomic status (SES) groups with associations only seen in the low SES group. These results were not explained by threshold effects or by the different SES groups representing different parts of the cognitive test score distribution. Three other possible explanations of these results are discussed: sub clinical vascular disease drives the observed association but no effect is observed in the high SES group due to compensation provided by greater cognitive reserve, cognition is a marker of overall bodily integrity particularly in low-SES groups, and SES is a moderator of the association between cognition and CHD, because it marks a range of other risk factors.

Impaired adult cognition predicts future health outcomes like dementia (Chertkow, 2002; Morris et al., 2001) and mortality (Fried et al., 1998; Bassuk et al., 2000; Gale et al., 1996; Dewey & Saz, 2001), and there is some evidence to link it to health functioning at older ages (Mehta et al., 2002). However, there is little research on adult cognition as a risk factor for chronic diseases at older ages. The emerging field of cognitive epidemiology posits such a role for cognitive function (Deary & Batty, 2007). The objective of this paper is to examine whether cognitive function is a risk factor for coronary heart disease (CHD). CHD is a global problem, with the risk of disease shown to increase as societies undergo urbanization (Yusuf et al., 2001). In many western countries, including the United Kingdom, it remains the leading cause of death (2007).

Examining the status of cognition as a risk factor for CHD is complicated by the fact that vascular risk factors and indicators of vascular disease are established risk factors for both cognitive impairment (Breteler et al., 1994; Desmond et al., 1993; Launer et al., 1995) and dementia (Breteler, 2000; de la Torre, 2002; Shi et al., 2000; Aronson et al., 1990). The atherosclerotic process and related hypoperfusion is seen to be responsible for this association (de la Torre, 2002). However, dementia has also been shown to be a risk factor for future heart disease (Bursi et al., 2006). Clearly, cause and effect is difficult to tease apart in very elderly populations due to high levels of co-morbidities. Even in younger populations the results that show an association between cognition and CHD may be driven by the effects of underlying cardiovascular risk factors. Furthermore, few studies have studied whether the association between cognition and CHD is independent of socioeconomic status (SES); SES is associated with both CHD (Yusuf et al., 2001) and cognition (Singh-Manoux et al., 2005).

Data from the Whitehall II study allowed us to assess the association between cognition and incidence of CHD, with the possibility of adjusting for a range of cardiovascular risk factors. A further reason of examining the association between cognition and CHD in the Whitehall II study was the opportunity to assess whether SES modified the association. To improve outcome precision, we included a range of cognitive tests, considered them individually and then in combination using factor analysis to constitute a “general” cognitive factor.

Methods

Data are drawn from the Whitehall II study, established in 1985 as a longitudinal study to examine the socioeconomic gradient in health and disease among 10,308 civil servants (6,895 men and 3,413 women) (Marmot & Brunner, 2005). All civil servants aged 35–55 years in 20 London based departments were invited to participate by letter, and 73% agreed. Baseline screening (Phase 1) took place during 1985–1988, and involved a clinical examination and a self-administered questionnaire containing sections on demographic characteristics, health, lifestyle factors, work characteristics, social support and life events. The clinical examination included measures of blood pressure, anthropometry, biochemical measurements, neuroendocrine function, and sub clinical markers of cardiovascular disease. Subsequent phases of data collection have alternated between postal questionnaire alone (Phases 2 (1989–1990), 4 (1995–1996), 6 (2001) and 8 (2006)) and postal questionnaire accompanied by a clinical examination (Phases 3 (1991–1993), 5 (1997–1999) and 7 (2002–2004)). The University College London ethics committee approved the study.

Cognitive function

was assessed at Phase 5 using a battery of five standard tasks, described below.

Short-term verbal memory

was assessed with a 20-word free recall test. Participants were presented a list of 20 one or two syllable words at two second intervals and were then asked to recall in writing as many of the words in any order and had two minutes to do so.

The Alice Heim 4-I (AH4-I)

is composed of a series of 65 verbal and mathematical reasoning items of increasing difficulty (Heim, 1970). It tests inductive reasoning, measuring the ability to identify patterns and infer principles and rules. Participants had 10 minutes to do this section.

Vocabulary

was assessed using the Mill Hill Vocabulary test (Raven, 1965), used in its multiple-choice format, consisting of a list of 33 stimulus words ordered by increasing difficulty and six response choices.

We used two measures of verbal fluency: phonemic and semantic (Borkowski JG et al., 1967). Phonemic fluency was assessed via “S” words and semantic fluency via “animal” words. Subjects were asked to recall in writing as many words beginning with “S” and as many animal names as they could. One minute was allowed for each test.

Principal component analysis of these 5 cognitive measures was used to construct a composite measure of the general cognitive (‘g’) factor (Plomin, 1999). The first factor accounted for 56% of the variance and the factor loadings were 0.32 for memory, 0.50 for AH4-I, 0.46 for Mill Hill, 0.45 for phonemic fluency and 0.49 for semantic fluency.

Incident CHD

events included coronary death (ICD 9 codes 410–414 or ICD 10 codes I20–25), non-fatal myocardial infarction (MI) and definite angina. MI was determined using data from questionnaires, study ECGs, hospital acute ECGs, cardiac enzymes, and physician records following MONICA criteria (Tunstall-Pedoe et al., 1994). Angina was assessed based on the participant’s reports of symptoms (Rose et al., 1977), with corroboration in medical records for nitrate medication use or abnormalities on a resting electrocardiogram, an exercise electrocardiogram, or a coronary angiogram. We excluded angina cases that were based solely on self-reported data. The independent variable in our analysis is cognitive function and the dependent variable is CHD, starting the follow-up period for CHD subsequent to cognitive testing ensures that we only include “incident” events. All participants with prevalent CHD were excluded from the analysis.

Covariates

used were age, sex, sociodemographic variables, cardiovascular risk factors and health behaviors, all assessed at Phase 5.

Socio-demographic variables

were composed of marital status (married/cohabiting, single, widowed, and divorced/separated), education (no academic qualifications, lower secondary school, higher secondary school, university, and higher university degree) and last civil service employment grade at Phase 5, classified into high, intermediate and low grade. Employment grade in the Whitehall II study is a comprehensive marker of SES and is related to salary, social status and level of responsibility.

Cardiovascular risk factors

included diabetes, based on 2-hr glucose tolerance test or fasting glucose results using WHO criteria (Alberti & Zimmet, 1998) or self-reports. Systolic and diastolic blood pressure were measured twice with the participant sitting after a 5-minute rest using the Hawksley random-zero sphygmomanometer. The average of these two readings was taken to be the measured blood pressure. Serum cholesterol was measured within 72 hours in serum stored at 4°C using enzymatic colorimetric methods. We also adjusted for cardiovascular disease medication; diuretics, beta-blockers, ACE and AII inhibitors, calcium channel blockers and other antihypertensive drugs, lipid lowering drugs, nitrates and antiplatelet drugs.

Health behaviors

were assessed from questionnaire data; smoking (current, past, never), alcohol consumption (units of alcohol consumed last week), frequency of fruit and vegetable consumption (single item measure on a 8-point scale, ranging from ‘seldom or never’ to ‘two or more times a day’), and hours of physical activity (sum of the hours of weekly moderate and vigorous physical activities in response to a 20-item questionnaire on the frequency and duration of participation in walking, cycling, sports, gardening, housework, and home maintenance).

Statistical analysis

We first examined the form of the cognition-CHD relationships in order to ensure that all these associations could be adequately described using a single linear term across the whole distribution of cognitive scores. Tests for non-linearity in the associations between cognitive measures and CHD were performed using the SAS macro rcs.mac (Heinzl & Kaider, 2007). We then examined whether the association between cognition and incident CHD was similar in men and women by fitting appropriate interaction terms. We modeled the association between each cognitive measure and CHD using Cox proportional hazards regression models after confirming that the proportionality assumption was not violated (p for interaction of cognitive scores with log(time) > 0.35 for all cognitive tests). We present these results by showing the hazard ratio of CHD associated with a one standard deviation decrease in each cognitive measure. The analyses were first adjusted for age and sex (model 1). Subsequent models were further adjusted for socio-demographic measures (model 2), cardiovascular risk factors (model 3) and health behaviors (model 4). The analyses were performed using SAS statistical software, version 9.1.

Results

We present results for incident CHD events among those who did not have a history of CHD. At phase 5, 7830 individuals were still participating in the study. Data on all covariates included in the analysis were available for 5628 individuals. After excluding those with a previous CHD event, 5292 participants remained; 28 percent were women. At the start of the follow-up period individuals were on average 55.4 (Standard Deviation (SD)=6.0) years old and the mean follow-up period was 6.4 years (SD=1.0). One hundred and eighty-one incident CHD events were observed over the follow-up period. Table 1 presents the sample characteristics in those with and without a subsequent CHD event.

Table 1
Sample characteristics of participants in those with and without subsequent incident CHD.

We examined the correlations between the ‘general’ cognitive factor and the continuously measured covariates. Higher scores were associated with age inversely (r=−0.25, p<0.01), more physical activity (r=0.08, p<0.01), greater alcohol consumption (r=0.27, p<0.01), more frequent fruit and vegetable consumption (r=0.19, p<0.01), higher education (r=0.45, p<0.01), higher grade (measured in 6 categories, r=0.56, p<0.01), with both lower diastolic (r=−0.04, p<0.01) and systolic (r=−0.10, p<0.01) blood pressure but not with cholesterol (r=−0.02, p=0.13).

For all cognitive measures, there was no evidence of non-linearity in the association with CHD (the p for non-linearity was 0.11 for the ‘general’ cognitive factor, 0.42 for memory, 0.06 for the AH4-I, 0.36 for Mill-Hill, 0.41 for phonemic and 0.16 for semantic fluency). The results for the interaction terms provide no evidence for sex differences in the association between cognitive measures and incident CHD (all p from 0.09 to 0.79) justifying combined analyses of men and women. However, since there was some evidence of an interaction with SES (the interaction term in model 1 was 0.05 for the ‘general’ cognitive factor, 0.18 for memory, 0.06 for the AH4-I, 0.52 for Mill-Hill, 0.34 for phonemic and 0.08 for semantic fluency), we will first show results on the whole sample and then show the results stratified by SES.

In the whole sample, a one standard deviation lower score on the “general” cognitive factor was associated with a 17% greater risk of incident CHD in the analysis adjusted for age and sex (Hazard Ratio (HR)=1.17; 95% confidence interval (CI)=1.01–1.37) – Table 2. This association was much attenuated after adjustment for cardiovascular risk factors and health behaviors (HR=1.10; 95% CI=0.95–1.27). However, a one standard deviation lower score in the AH4-I (HR=1.26; 95% CI=1.06–1.52) and Mill-Hill (HR=1.24; 95% CI=1.04–1.47) remained associated with 24–26% excess incidence of CHD in the fully adjusted analysis (model 4).

Table 2
The association between cognition and incident coronary heart disease (CHD).

In further analysis we examined the association between cognition and CHD in analysis stratified by SES. The stratified analyses are on two groups: the high SES and low SES group, the latter combined the intermediate and low grades due to the small number of CHD events and similarity in the association between cognition and CHD. Table 3 shows the mean and standard deviation for the 5 cognitive tests in the total population and in the two SES groups. Table 4 shows the association between cognition and incident CHD separately in the high and low SES groups; the results show no evidence of an association between cognitive scores and CHD in the high SES group. However, in the lower SES group the general “cognitive” factor (HR=1.28; 95% CI=1.01–1.62) and specific measures, such as AH4-I (HR=1.35; 95% CI=1.07–1.69) and Mill Hill (HR=1.23; 95% CI=1.00–1.50), were all associated with incident CHD in analysis adjusted for all covariates (model 4).

Table 3
Cognition function measures in the total population and the high and low SES groups.
Table 4
The association between cognition (decrease by one standard deviation) and incident coronary heart disease (CHD).

Discussion

This paper presents two key findings. First, some cognitive test scores are associated with incident CHD in middle-aged individuals; aged on average 55 years at the start of the follow-up. The association is evident with measures of reasoning and vocabulary but not with measures of memory and verbal fluency. Second, SES moderates the association between cognition and CHD so that in the high SES group cognitive measures show no association with incidence of coronary heart disease. Thus, the first finding reported here is evident in the lower socioeconomic groups only.

These findings need to be considered in light of the fact that vascular pathology is seen as one of the three key determinants of cognitive ageing and dementia outcomes (Holland & Rabbitt, 1991). Our own previous work has shown history of CHD to be associated with poor cognitive function, with stronger effects for long-standing CHD (Singh-Manoux et al., 2008b). The cognitive test battery was introduced at the Phase 5 of the Whitehall II study, when participants were on average 55 years old, in order to study the social, behavioral and biological determinants of cognitive ageing. Although the tests assess a range of cognitive abilities, they all tap into verbal ability, except the numerical part of the AH4-I, and are well suited to this white-collar cohort. As our primary concern is research on associations between cognition and health rather than intelligence per se, it is possible that our ‘general’ cognitive score might not be equivalent to other constructions of the ‘g’ score.

The objective of the present paper is to examine the association the other way around to assess whether poor cognition is a risk factor for CHD in individuals free of manifest disease at baseline at mean age 55. A major difference from our previous work is that the results reported here are based on late onset CHD. It is important to recognize that cognition and health outcomes have reciprocal effects with the importance of one over the other varying over the lifecourse. The mechanisms linking vascular risk factors to cognitive outcomes in the elderly are much researched and fairly well established (Breteler et al., 1994; Desmond et al., 1993; Launer et al., 1995; Breteler, 2000; de la Torre, 2002; Shi et al., 2000). In contrast, the mechanisms that would make cognition a risk factor for CHD are less well understood. One comprehensive framework suggests that intelligence influences health as it is a record of bodily insults, an indictor of system integrity, is related to healthy behaviors and is a predictor of entry into safer environments (Whalley & Deary, 2001). Our analysis adjusts for education, health behaviors and many cardiovascular risk factors to examine these different pathways. Even though our results show some attenuation on adjustment for cardiovascular risk factors and health behaviors, the cognition-CHD association is robust and dependent on employment grade, a comprehensive measure of SES in our cohort. As this is a new finding, we will devote the rest of the discussion to this issue. We propose and discuss four possible explanations.

First, one possible explanation for observing differing associations in high and low SES groups may be a consequence of threshold effects in the association between cognition and subsequent CHD. If this was the case then differing distributions of cognitive scores between the two SES groups might result in differing associations. Even though our results show differences between the two SES groups, these are not large enough to lead to the current results observed with CHD. Furthermore, associations of the cognitive scores with CHD were consistent with a linear relationship across the whole distribution of scores. Thus, the differential results by SES seem not to be due to the different SES groups representing different parts of the cognitive test score distribution.

The second explanation is drawn from work on the association between cognition and mortality that advances the view that cognition may be a marker of ‘bodily integrity’ and in this way be associated with health outcomes (Shipley et al., 2007; Whalley & Deary, 2001). This is one of the four principal mechanisms proposed to explain the association between early life cognition and subsequent mortality (Whalley & Deary, 2001). If there is an SES difference in ‘bodily integrity’ then our cognitive measures do not capture it.

A third explanation of the results is that, as previously shown (Bell & Dominici, 2008; Kelly et al., 2001), socioeconomic factors can indeed act as moderating variables. A moderator (or an effect modifier) is a variable where the degree of association between an exposure and an outcome variable changes according to its value. The effect modification hypothesis would suggest that poorer cognitive status in the low SES group is also associated with other factors like underlying health status and other health behaviors not taken into account in the analysis. Thus, low cognitive scores create vulnerability in the lower socioeconomic groups because they are associated with a range of other risk factors. Considering that our covariates comprised major established major risk factors for CHD and that adjusting analyses for them had little effect on the associations, it remains unclear what specifically these other underlying factors could be.

Finally, a further explanation of the results involves cognitive reserve, seen broadly as the ability of an individual to tolerate progressive brain pathology without manifestation of clinical cognitive symptoms (Stern, 2002). It is possible that subclinical vascular disease creates an association between cognition and CHD in the lower SES group but has no impact in the high SES group due to the compensation provided by greater cognitive reserve. We have previously shown common carotid artery intima media thickness (IMT), a measure of generalized atherosclerosis, to be associated with cognitive function in the low but not the high SES group (Singh-Manoux et al., 2008a). Thus, it is possible that the results reported here reflect an effect of subclinical disease rather than cognition as a risk factor for CHD.

There are some limitations to the results reported in this paper. First, the analysis on CHD is on small numbers and includes incidence of CHD after Phase 5, when participants were on average 55 years old. Cognition was for the first time measured on the full Whitehall II population at Phase 5 and we chose to examine the association between cognition and CHD prospectively so all CHD events prior to Phase 5, constituting the majority of cases, were excluded from the analysis. However, in uix 1 we provide the analysis using all CHD events, 547 events instead of the 181 analysed for this paper, and the results are no different to those reported above. A further limitation is that the analysis is based on British white-collar civil servants and may not apply to wider populations. However, generalizability may be less limited than first imagined. The majority of the working population in post-industrial countries is now employed in white collar jobs, and Whitehall II participants cover a wide range of employment grades with annual full-time salaries in 1995 ranging from $10,006 U.S.(£4995) to $300,480 U.S. (£150,000).

In conclusion, we show an association between cognition and incident CHD to be dependent on SES and discuss four possible explanations. Our analysis does not allow us to pick one explanation over another, although there is little support for the threshold explanation in our data. Interest in the interaction between SES and cognition in predicting health outcomes is increasingly manifest in the research literature and it appears that these might have both shared and unique effects on health (Singh-Manoux et al., 2005; Batty et al., 2006). One of the challenges of cognitive epidemiology, when defined essentially as an interest in cognitive measures as risk factors for health (Deary & Batty, 2007), is to delineate the effects of cognition and socioeconomic factors on health.

Acknowledgement

We thank all of the participating civil service departments and their welfare, personnel, and establishment officers; the British Occupational Health and Safety Agency; the British Council of Civil Service Unions; all participating civil servants in the Whitehall II study; and all members of the Whitehall II study team.

Funding

AS-M is supported by a “European Young Investigator Award” from the European Science Foundation; MK by the Academy of Finland (grants 117604, 124332, 124327); MM by an MRC research professorship; JEF by the MRC (Grant number G8802774) and MJS by the British Heart Foundation. The Whitehall II study has been supported by grants from the British Medical Research Council (MRC); the British Heart Foundation; the British Health and Safety Executive; the British Department of Health; the National Heart, Lung, and Blood Institute (grant HL36310); the National Institute on Aging (grant AG13196); the Agency for Health Care Policy and Research (grant HS06516); and the John D. and Catherine T. MacArthur Foundation Research Networks on Successful Midlife Development and Socioeconomic Status and Health.

Appendix

Appendix 1
The association of cognition with all (prevalent and incident) events of coronary heart disease (CHD) in the Whitehall II study.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Reference List

  • Coronary heart disease. Department of Health. 2007. [On-line].
  • Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet.Med. 1998;15:539–553. [PubMed]
  • Aronson MK, Ooi WL, Morgenstern H, Hafner A, Masur D, Crystal H, et al. Women, myocardial infarction, and dementia in the very old. Neurology. 1990;40:1102–1106. [PubMed]
  • Bassuk SS, Wypij D, Berkman LF. Cognitive impairment and mortality in the community-dwelling elderly. Am.J.Epidemiol. 2000;151:676–688. [PubMed]
  • Batty GD, Der G, Macintyre S, Deary IJ. Does IQ explain socioeconomic inequalities in health? Evidence from a population based cohort study in the west of Scotland. BMJ. 2006;332:580–584. [PMC free article] [PubMed]
  • Bell ML, Dominici F. Effect modification by community characteristics on the short-term effects of ozone exposure and mortality in 98 US communities. Am J Epidemiol. 2008;167:986–997. [PMC free article] [PubMed]
  • Borkowski JG, Benton AL, Spreen O. Word fluency and brain damage. Neuropsychologica. 1967;5:135–140.
  • Breteler MM. Vascular involvement in cognitive decline and dementia. Epidemiologic evidence from the Rotterdam Study and the Rotterdam Scan Study. Ann.N.Y.Acad.Sci. 2000;903:457–465. [PubMed]
  • Breteler MM, van Swieten JC, Bots ML, Grobbee DE, Claus JJ, van den Hout JH, et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology. 1994;44:1246–1252. [PubMed]
  • Bursi F, Rocca WA, Killian JM, Weston SA, Knopman DS, Jacobsen SJ, et al. Heart disease and dementia: a population-based study. Am.J.Epidemiol. 2006;163:135–141. [PubMed]
  • Chertkow H. Mild cognitive impairment. Curr.Opin.Neurol. 2002;15:401–407. [PubMed]
  • de la Torre JC. Alzheimer disease as a vascular disorder: nosological evidence. Stroke. 2002;33:1152–1162. [PubMed]
  • Deary IJ, Batty GD. Cognitive epidemiology. J.Epidemiol.Community Health. 2007;61:378–384. [PMC free article] [PubMed]
  • Desmond DW, Tatemichi TK, Paik M, Stern Y. Risk factors for cerebrovascular disease as correlates of cognitive function in a stroke-free cohort. Arch.Neurol. 1993;50:162–166. [PubMed]
  • Dewey ME, Saz P. Dementia, cognitive impairment and mortality in persons aged 65 and over living in the community: a systematic review of the literature. Int.J.Geriatr.Psychiatry. 2001;16:751–761. [PubMed]
  • Fried LP, Kronmal RA, Newman AB, Bild DE, Mittelmark MB, Polak JF, et al. Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study. JAMA. 1998;279:585–592. [PubMed]
  • Gale CR, Martyn CN, Cooper C. Cognitive impairment and mortality in a cohort of elderly people. BMJ. 1996;312:608–611. [PMC free article] [PubMed]
  • Heim AW. AH 4 group test of general Intelligence. Windsor, UK: NFER-Nelson Publishing Company Ltd; 1970.
  • Heinzl H, Kaider A. Manual for the SAS-Macro RCS. 2007. http://www.meduniwien.ac.at/msi/biometrie/programme/Rcs.htm [On-line].
  • Holland CA, Rabbitt PMA. The Course and causes of Cognitive Change with Advancing age. Reviews in Clinical Gerontology. 1991;1:81–96.
  • Kelly YJ, Nazroo JY, McMunn A, Boreham R, Marmot M. Birthweight and behavioural problems in children: a modifiable effect? Int.J.Epidemiol. 2001;30:88–94. [PubMed]
  • Launer LJ, Masaki K, Petrovitch H, Foley D, Havlik RJ. The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. JAMA. 1995;274:1846–1851. [PubMed]
  • Marmot M, Brunner E. Cohort Profile: the Whitehall II study. Int.J Epidemiol. 2005;34:251–256. [PubMed]
  • Mehta KM, Yaffe K, Covinsky KE. Cognitive impairment, depressive symptoms, and functional decline in older people. J Am Geriatr.Soc. 2002;50:1045–1050. [PMC free article] [PubMed]
  • Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch.Neurol. 2001;58:397–405. [PubMed]
  • Plomin R. Genetics and general cognitive ability. Nature. 1999;402:C25–C29. [PubMed]
  • Raven JC. Guide to using the Mill Hill vocabulary test with progressive matrices. London, UK: HK Lewis; 1965.
  • Rose G, Hamilton PS, Keen H, Reid DD, McCartney P, Jarrett RJ. Myocardial ischaemia, risk factors and death from coronary heart-disease. Lancet. 1977;1:105–109. [PubMed]
  • Shi J, Perry G, Smith MA, Friedland RP. Vascular abnormalities: the insidious pathogenesis of Alzheimer's disease. Neurobiol.Aging. 2000;21:357–361. [PubMed]
  • Shipley BA, Der G, Taylor MD, Deary IJ. Association between mortality and cognitive change over 7 years in a large representative sample of UK residents. Psychosom.Med. 2007;69:640–650. [PubMed]
  • Singh-Manoux A, Britton A, Kivimaki M, Gueguen A, Halcox J, Marmot M. Socioeconomic status moderates the association between carotid intima-media thickness and cognition in midlife: evidence from the Whitehall II study. Atherosclerosis. 2008a;197:541–548. [PMC free article] [PubMed]
  • Singh-Manoux A, Ferrie JE, Lynch JW, Marmot M. The role of cognitive ability (intelligence) in explaining the association between socioeconomic position and health: evidence from the Whitehall II prospective cohort study. Am J Epidemiol. 2005;161:831–839. [PubMed]
  • Singh-Manoux A, Sabia S, Lajnef M, Ferrie JE, Nabi H, Britton AR, et al. History of coronary heart disease and cognitive deficit in midlife: the Whitehall II study. Eur.Heart J. 2008b;29:2100–2107. [PMC free article] [PubMed]
  • Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J.Int.Neuropsychol.Soc. 2002;8:448–460. [PubMed]
  • Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation. 1994;90:583–612. [PubMed]
  • Whalley LJ, Deary IJ. Longitudinal cohort study of childhood IQ and survival up to age 76. BMJ. 2001;322:1–5. [PMC free article] [PubMed]
  • Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation. 2001;104:2855–2864. [PubMed]